Form 4 for SNDX Syndax Pharmaceuticals Inc
Accepted 2022-07-05 00:00:00 ET · period of report 2022-07-01 · accession 0001562180-22-005475 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-07-05 | 2022-07-01 | SNDX | Morrison Briggs | Pres, Head of R, D, Dir | M - OptEx | $7.20 | +62.3K | 80.1K | +349% | +$448.5K |
| D | 2022-07-05 | 2022-07-01 | SNDX | Morrison Briggs | Pres, Head of R, D, Dir | S - Sale+OE | $19.00 | -62.3K | 17.8K | -78% | -$1.18M |
| D | 2022-07-05 | 2022-07-01 | SNDX | Morrison Briggs | Pres, Head of R, D, Dir | M - OptEx | $0.00 | -62.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-01 | M | A | 62,292 | $7.20 | 80,128 | D | — | — | |
| 2 | Common | Common Stock | 2022-07-01 | S | D | 62,292 | $19.00 | 17,836 | D | — | — | (F2) The sale prices ranged from $18.61 to $19.38 |
| 3 | Derivative | Stock Options (Right to buy) | 2022-07-01 | M | D | 62,292 | $0.00 | 0 | D | $7.20 · — to 2025-06-30 | 62,292 Common Stock | (F3) This option is fully vested. |